Sound Bioventures | Activity | F4

Team Portfolio Raise Champions Essays

F4/Sound Bioventures/Activity

Sound Bioventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

New Fund

Secured DKK 150M from EIFO for its second fund, registered in Sweden in April 2025; Novo Holdings reinvested.

Fund II

Sound Bioventures

Added recently

Investment

Existing investor in AnaCardio's EUR 62.5M Series B for heart failure therapy.

AnaCardio

AnaCardio Sound Bioventures

soundbioventures.comSEP 30, 2026

SEP 30, 2026

Investment

Participated as an existing syndicate member in Breye Therapeutics' EUR 67.5M Series A.

Breye Therapeutics

Breye Therapeutics Sound Bioventures

soundbioventures.comSEP 29, 2026

SEP 29, 2026

Milestone

Teitur reported successful Phase I results for first-in-class Parkinson's peptide TT-P34.

Teitur Trophics

Teitur Trophics Sound Bioventures

soundbioventures.comSEP 10, 2026

SEP 10, 2026

Milestone

VarmX enrolled the first participant in its global Phase 3 EquilibriX-S trial of VMX-C001.

VarmX

VarmX Sound Bioventures

soundbioventures.comAUG 20, 2026

AUG 20, 2026

Investment

Fund I's latest new investment, in cell therapy company BOOST Pharma.

BOOST Pharma

BOOST Pharma Sound Bioventures

pitchbook.comNOV 3, 2025

NOV 3, 2025